Drug repurposing in cardiovascular diseases: Opportunity or hopeless dream?

Cardiovascular disease remains – despite the development of new drugs, devices, and therapeutic strategies – the leading cause of death and disability worldwide. There is therefore a great need to implement the pharmacological armamentarium, considering also the need to balance the therapeutic and the side effects. Furthermore, the best choice among the drug treatment options and reduction of side effects remain urgent problems for studies of...